Related Experiment Video
Updated: Oct 19, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
What about the others: differential diagnosis of COVID-19 in a German emergency department
David Fistera1,2, Annalena Härtl3, Dirk Pabst3
1Center of Emergency Medicine, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany. David.fistera@uk-essen.de.
Insights
COVID-19 presented diagnostic challenges in emergency departments. COVID-19 patients experienced longer hospital stays and higher mortality than those with other respiratory infections.
Area of Science:
- Emergency Medicine
- Infectious Diseases
- Clinical Diagnostics
Background:
- COVID-19 pandemic poses significant challenges to healthcare systems, particularly emergency medicine.
- Accurate and timely triage in the emergency department (ED) is critical for effective COVID-19 patient management.
- Distinguishing COVID-19 symptoms from other common diseases in the ED is clinically challenging.
Purpose of the Study:
- To compare clinical characteristics and outcomes of COVID-19 patients with non-COVID-19 patients presenting with similar symptoms.
- To identify differences in laboratory parameters, symptoms, and vital signs between COVID-19 and non-COVID-19 respiratory infections.
- To evaluate the severity of COVID-19 airway infections compared to other respiratory infections.
Main Methods:
- Retrospective analysis of 314 patients with suspected COVID-19 symptoms in German emergency departments during the first wave.
- RT-PCR testing for SARS-CoV-2 on nasopharyngeal swabs for all patients.
- Comparison of laboratory parameters, symptoms, and vital signs between 47 COVID-19 positive patients and 267 COVID-19 negative patients, focusing on respiratory infections.
Main Results:
- Among COVID-19 negative patients, respiratory diseases were the most common diagnosis (42.7%).
- COVID-19 patients reported less dyspnea but more dysgeusia compared to COVID-19 negative respiratory infections.
- COVID-19 patients had significantly longer hospital stays (9.0 vs. 5.6 days) and higher mortality (OR 3.979).
Conclusions:
- COVID-19 should be considered in the differential diagnosis for various emergency department presentations.
- Clinical signs, symptoms, and laboratory results alone cannot reliably differentiate COVID-19 from other respiratory infections.
- COVID-19 airway infections appear to have a more severe clinical course requiring hospitalization compared to other respiratory infections.
Background:
The ongoing COVID-19 pandemic remains a major challenge for worldwide health care systems and in particular emergency medicine. An early and safe triage in the emergency department (ED) is especially crucial for proper therapy. Clinical symptoms of COVID-19 comprise those of many common diseases; thus, differential diagnosis remains challenging.
Method:
We performed a retrospective study of 314 ED patients presenting with conceivable COVID-19 symptoms during the first wave in Germany. All were tested for COVID-19 with SARS-Cov-2-nasopharyngeal swabs. Forty-seven patients were positive. We analyzed the 267 COVID-19 negative patients for their main diagnosis and compared COVID-19 patients with COVID-19 negative respiratory infections for differences in laboratory parameters, symptoms, and vital signs.
Results:
Among the 267 COVID-19 negative patients, 42.7% had respiratory, 14.2% had other infectious, and 11.2% had cardiovascular diseases. Further, 9.0% and 6.7% had oncological and gastroenterological diagnoses, respectively. Compared to COVID-19 negative airway infections, COVID-19 patients showed less dyspnea (OR 0.440; p = 0.024) but more dysgeusia (OR 7.631; p = 0.005). Their hospital stay was significantly longer (9.0 vs. 5.6 days; p = 0.014), and their mortality significantly higher (OR 3.979; p = 0.014).
Conclusion:
For many common ED diagnoses, COVID-19 should be considered a differential diagnosis. COVID-19 cannot be distinguished from COVID-19 negative respiratory infections by clinical signs, symptoms, or laboratory results. When hospitalization is necessary, the clinical course of COVID-19 airway infections seems to be more severe compared to other respiratory infections.
Trial Registration:
German Clinical Trial Registry DRKS, DRKS-ID of the study: DRKS00021675 date of registration: May 8th, 2020, retrospectively registered.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests

